Home›People›Karin Payne
Karin Payne

Karin Payne

Chief Development Officer at Renovare Therapeutics.

Executive
Updated Nov 9, 2026·Latest SEC filing Oct 2, 2026·Suggest an edit

About Karin Payne

Karin Payne is a chief development officer at Renovare Therapeutics.

Experience

This experience comes from SEC filings. The years are when the filings name Karin Payne in the role, so the role may have started earlier or lasted longer.

Renovare Therapeutics, Inc.
Chief Development Officer
2026 · Boulder, CO
Develops regenerative treatments for people with osteoarthritis.

Key Colleagues at Startups

The people Karin Payne works with at each company, as listed on that company's latest Form D.

Renovare Therapeutics, Inc. · Form D, Oct 2, 2026
Elizabeth Scott
Elizabeth Scott
Chief Executive Officer and director
Stephanie Bryant
Stephanie Bryant
Chief Scientific Officer and director

Sources

  1. SECRenovare Therapeutics, Inc. Form D, filed Oct 2, 2026